Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tabernero

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1980
Influence of hepatic and renal disorders on the pharmacokinetics of sulfachloropyridacineE L Mariño, A Dominguez-Gil, J M Tabernero, et al.
International Journal of Clinical Pharmacology and Biopharmacy|August 1, 1979
Pharmacokinetics of cefoxitin in patients undergoing hemodialysisM J Garcia, A Dominguez-Gil, J M Tabernero, et al.
International Journal of Clinical Pharmacology and Biopharmacy|April 1, 1979
Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal functionJ M Lanao, A Domínguez-Gil, J M Tabernero, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 17, 1998
Changes in coagulation and fibrinolysis in the postoperative period immediately after kidney transplantation in patients receiving OKT3 or cyclosporine A as induction therapyJ Deira, I Alberca, J L Lerma, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Pharmacokinetics of cefoxitin during haemofiltrationM J Garcia, A Dominguez-Gil, J M Tabernero, et al.
Klinische Wochenschrift|January 4, 1991
Effects of subclinical hyperthyroidism on renal handling of water and electrolytes in patients with nodular goiterJ J Corrales, J M Tabernero, J M Miralles, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Alpha-fetoprotein-concanavalin A binding as a marker to discriminate between germ cell tumours and liver diseasesJ Mora, N Gascón, J M Tabernero, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1986
Pharmacokinetics of cefotiam during hemofiltrationI G Alonso, E L Mariño, A Dominguez-Gil, et al.
Transplantation Proceedings|September 1, 2009
Non-skin solid tumors as a cause of morbidity and mortality after liver transplantationP Fraile, P García-Cosmes, P Martín, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|January 26, 2010
[Clinical analysis of a population with autosomal dominant polycystic kidney disease]P Fraile Gómez, P García-Cosmes, L Gorbacho Becerra, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1980
Influence of hepatic and renal disorders on the pharmacokinetics of sulfachloropyridacineE L Mariño, A Dominguez-Gil, J M Tabernero, et al.
International Journal of Clinical Pharmacology and Biopharmacy|August 1, 1979
Pharmacokinetics of cefoxitin in patients undergoing hemodialysisM J Garcia, A Dominguez-Gil, J M Tabernero, et al.
International Journal of Clinical Pharmacology and Biopharmacy|April 1, 1979
Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal functionJ M Lanao, A Domínguez-Gil, J M Tabernero, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 17, 1998
Changes in coagulation and fibrinolysis in the postoperative period immediately after kidney transplantation in patients receiving OKT3 or cyclosporine A as induction therapyJ Deira, I Alberca, J L Lerma, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Pharmacokinetics of cefoxitin during haemofiltrationM J Garcia, A Dominguez-Gil, J M Tabernero, et al.
Klinische Wochenschrift|January 4, 1991
Effects of subclinical hyperthyroidism on renal handling of water and electrolytes in patients with nodular goiterJ J Corrales, J M Tabernero, J M Miralles, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Alpha-fetoprotein-concanavalin A binding as a marker to discriminate between germ cell tumours and liver diseasesJ Mora, N Gascón, J M Tabernero, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1986
Pharmacokinetics of cefotiam during hemofiltrationI G Alonso, E L Mariño, A Dominguez-Gil, et al.
Transplantation Proceedings|September 1, 2009
Non-skin solid tumors as a cause of morbidity and mortality after liver transplantationP Fraile, P García-Cosmes, P Martín, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|January 26, 2010
[Clinical analysis of a population with autosomal dominant polycystic kidney disease]P Fraile Gómez, P García-Cosmes, L Gorbacho Becerra, et al.
Pageof 9